ALDH1 expression correlates with favorable prognosis in ovarian cancers - Test2 - elhamkhani - TriplyDB

ALDH1 expression correlates with favorable prognosis in ovarian cancers

ALDH1 expression correlates with favorable prognosis in ovarian cancers

http://www.wikidata.org/entity/Q24649718

about

Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers Molecular characterization, expression analysis, and role of ALDH3B1 in the cellular protection against oxidative stress Aldehyde dehydrogenase 1A1 in stem cells and cancer Cancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinoma Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma Morphological and immunohistochemical study of ovarian and tubal dysplasia associated with tamoxifen Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer Aldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cells Aldehyde dehydrogenase 3B1 (ALDH3B1): immunohistochemical tissue distribution and cellular-specific localization in normal and cancerous human tissues ALDH1 immunohistochemical expression and its significance in salivary adenoid cystic carcinoma Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer.Differential expression of aldehyde dehydrogenase 1a1 (ALDH1) in normal ovary and serous ovarian tumors.ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH1 high expression is associated with poor prognosis Aberrant expression of retinoic acid signaling molecules influences patient survival in astrocytic gliomas.An imbalance in progenitor cell populations reflects tumour progression in breast cancer primary culture models.Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival Prognostic value of cancer stem cell marker aldehyde dehydrogenase in ovarian cancer: a meta-analysis Evaluation of stem cell properties in human ovarian carcinoma cells using multi and single cell-based spheres assays Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients Oxidative and reductive metabolism of lipid-peroxidation derived carbonyls.Ovarian cancer stem cell markers: prognostic and therapeutic implications.Relation of stem cell markers ALDH1 and CD44 with clinicopathological factors in urothelial carcinomas of urinary bladder.The expression of aldehyde dehydrogenase 1 (ALDH1) in ovarian carcinomas and its clinicopathological associations: a retrospective study Sex-determining region Y-box 2 expression predicts poor prognosis in human ovarian carcinoma.Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer.Early detection biomarkers for ovarian cancer.Endothelin receptor-A is required for the recruitment of antitumor T cells and modulates chemotherapy induction of cancer stem cells Small putative NANOG, SOX2, and SSEA-4-positive stem cells resembling very small embryonic-like stem cells in sections of ovarian tissue in patients with ovarian cancer Interleukin-1β promotes ovarian tumorigenesis through a p53/NF-κB-mediated inflammatory response in stromal fibroblasts.Prognostic values of aldehyde dehydrogenase 1 isoenzymes in ovarian cancer.Majority of differentially expressed genes are down-regulated during malignant transformation in a four-stage model Multiple pluripotent stem cell markers in human anaplastic thyroid cancer: the putative upstream role of SOX2.ALDH1 expression is enriched in breast cancers arising in young women but does not predict outcome.Aiming to immune elimination of ovarian cancer stem cells Aldehyde dehydrogenase 1 expression in primary and metastatic renal cell carcinoma: an immunohistochemistry study.Aldehyde dehydrogenase and ATP binding cassette transporter G2 (ABCG2) functional assays isolate different populations of prostate stem cells where ABCG2 function selects for cells with increased stem cell activity CD133 expression associated with poor prognosis in ovarian cancer.Evaluation of the Role of ALDH1 as Cancer Stem Cell Marker in Colorectal Carcinoma: An Immunohistochemical Study.Characterization of aldehyde dehydrogenase 1 high ovarian cancer cells: Towards targeted stem cell therapy.High ALDH1 expression correlates with better prognosis in tumorigenic malignant melanoma.

P2860

Q21562662-51C45704-9B86-4C39-B90D-A011026C2F9E Q24294878-6F9C9275-467D-41EA-AAA9-909CF253C0A3 Q26771185-BA070BA6-25D7-4214-A045-792DE129F37A Q26998068-3D874A91-8D11-435A-8828-C3E23D0F4F52 Q28474017-C8B064FF-9894-4CA1-AA78-D6273BAE4C92 Q33851264-94772B95-2059-415C-BBA3-11B11C7BF628 Q33943803-BA18385F-0CC1-4E48-BEB6-81D0298AAEF4 Q34026132-4F87D526-5E1F-4FD1-AEA0-B3CE30284068 Q34076679-05B5E2BD-DC96-476E-9805-C51AD83EE65C Q34293491-937EBE2C-9388-49FB-AB3A-451BB77B2E2E Q34420393-42CA209D-B8A5-476B-929A-6992EDE35263 Q34500251-86D200B8-46D3-4772-B138-05E7480FD488 Q34769665-E093E475-2925-4695-AB87-46143FF742C0 Q34838175-DB333D66-56C8-4F50-8A23-B5354AF6ED98 Q34980384-CDDA3677-85E6-40AB-9DDB-6729D225CF87 Q35022205-FC732C4E-75F9-4B11-BC89-27106CDE74C7 Q35055205-3B9D4882-DA53-4170-B3A9-B57472504187 Q35161888-06F8B4C1-1B5B-4007-8EB6-A64F240D4AE1 Q35177861-2B8BBF39-9920-4EFD-B147-A73F14728893 Q35554080-445DC041-CC63-4087-BA49-483283E37635 Q35606242-F6A0704B-37C0-4FAD-9A9F-69813190F5B0 Q35643960-A3E1F80A-791D-4158-B3DD-D8D31B23AB69 Q35684532-3F9B22C9-3C93-4F97-9E80-652EE57B6468 Q36028245-1BFED6B5-9DF0-433D-8191-834B0E7D883C Q36140826-C5199585-B2C7-4448-A274-74763DB7F52B Q36520143-94DFD70A-77A6-4091-A62F-B7E7E072F31F Q36608738-AEC54F4A-67DD-44FD-99D8-5E77D58B296B Q36651828-4716AD98-5E28-4311-BDEB-0ABB31AEE00D Q36730586-2C680220-AC2C-4AAC-8A0B-16A51B7FE9D6 Q36798021-CAA619D3-F7D7-4066-B1F5-891EEF700442 Q36798968-546ECEFE-3D2A-42D6-83DD-89BE5F2877C1 Q36991654-2F8C0322-9CA6-4705-8418-971A7964B94E Q37003353-13ECBC84-191E-46C4-80FB-EA1F137E8DAA Q37266548-70061B81-9E7C-4BBB-9549-199E379D0B45 Q37348476-EB2BEA34-BADC-49AE-B970-5DD071937403 Q37372279-938007BC-D689-4A40-8792-E2930383765B Q37373712-1AD53485-9C1A-428B-ACEC-0F300015D0E3 Q37663625-E4591112-2A19-4A58-8929-7B625DE67CE4 Q38782953-0DB458C2-5746-49E7-A95B-CB3EE34B9FD7 Q39010583-C5593F34-6C3A-4FF9-A6F2-6AF80D4B88E4

P2860

ALDH1 expression correlates with favorable prognosis in ovarian cancers

http://www.wikidata.org/entity/Q24649718

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

ALDH1 expression correlates with favorable prognosis in ovarian cancers

@ast

ALDH1 expression correlates with favorable prognosis in ovarian cancers

@en

ALDH1 expression correlates with favorable prognosis in ovarian cancers

@nl

type

label

ALDH1 expression correlates with favorable prognosis in ovarian cancers

@ast

ALDH1 expression correlates with favorable prognosis in ovarian cancers

@en

ALDH1 expression correlates with favorable prognosis in ovarian cancers

@nl

prefLabel

ALDH1 expression correlates with favorable prognosis in ovarian cancers

@ast

ALDH1 expression correlates with favorable prognosis in ovarian cancers

@en

ALDH1 expression correlates with favorable prognosis in ovarian cancers

@nl

P1433

Q24649718-4A374286-D56A-4691-A579-7BDF9E94D12B

P1476

Q24649718-5E0A63AF-F7B4-49F5-96B4-32013137E858

P2093

Q24649718-1F37BA7B-8FAE-465F-9633-207765014D66

Q24649718-35A18655-1073-4A27-AC61-BB4D59231E78

Q24649718-7BEE8ECD-5D19-40A2-8E6F-3ADA333F8687

Q24649718-A436B178-4805-48EB-B694-539D98C44AF9

Q24649718-C082DC2A-2FD4-40B6-ACF6-4934B6CE950A

Q24649718-CE4D0B6D-6597-44C2-8958-C21CB45BC00C

Q24649718-FE52FA95-757F-4348-A558-8FDFB44CB2DE

P2860

Q24649718-02A88B61-17C7-4EDE-B513-BB66BC01B91C

Q24649718-126F582F-F11D-4855-B8C9-AEE104BDCEBE

Q24649718-1B2DC0CA-65B7-4277-B7D5-151D10C066CA

Q24649718-1B8B3226-FA05-472B-A395-35783949DD43

Q24649718-20C8699A-15F5-458C-B508-0926BD121A66

Q24649718-2699C9FB-4E2E-45DD-B93D-C84982D75F9E

Q24649718-26B0C394-6350-4E0D-BFEA-C57F9255D54D

Q24649718-2CE300A6-6787-4271-8B63-B3D61071D46C

Q24649718-30E21D1D-AC1C-4D55-87DC-9DA212DBBF46

Q24649718-33CEFB9F-B167-43D2-9ED6-FB31E5731611

P2888

Q24649718-E0FF2EE2-854C-405C-9512-F23EA3D1A891

P304

Q24649718-65681E32-5C5C-4A8F-91E7-616F68C3BACA

P31

Q24649718-BC65C7AE-7A17-40C2-BCD9-C5FFC8BE0531

P3181

Q24649718-6D1C641F-AE6E-4268-980C-757E7229A51B

P356

Q24649718-2986CA1F-1690-470B-9510-E30FF9C57C25

P407

Q24649718-C3E0E8A7-19B8-46DB-8370-EF2A799A34CC

P433

Q24649718-1568644B-7533-4BF6-A1FB-5C16BA4B26ED

P478

Q24649718-F1BB6752-4A1B-4A56-9030-48FDA57237B4

P577

Q24649718-E7D9BD7D-F185-48FA-9FA6-FBB66CECC0F4

P5875

Q24649718-9C0A8762-C381-4DD2-9BB1-1FB55E33E3D5

P6179

Q24649718-CB867F87-9011-4701-B51B-2191DC2552B3

P698

Q24649718-D561D0D8-2284-493C-A811-25C33CB54A18

P921

Q24649718-D3297B4A-4B72-449E-A709-254875A5A5B3

P932

Q24649718-E30ED41A-5E15-4688-A216-C445E1150038

P3181

P356

MODPATHOL.2009.35

P1433

Modern Pathology

P1476

ALDH1 expression correlates with favorable prognosis in ovarian cancers

@en

P2093

Bin Chang

http://www.w3.org/2001/XMLSchema#string

Daniel G Rosen

http://www.w3.org/2001/XMLSchema#string

Fengxia Xue

http://www.w3.org/2001/XMLSchema#string

Guangzhi Liu

http://www.w3.org/2001/XMLSchema#string

Jinsong Liu

http://www.w3.org/2001/XMLSchema#string

Lianchun Xiao

http://www.w3.org/2001/XMLSchema#string

Xuemei Wang

http://www.w3.org/2001/XMLSchema#string

P2860

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Cancer statistics, 2008

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

Molecular definition of breast tumor heterogeneity

Metabolism of retinaldehyde and other aldehydes in soluble extracts of human liver and kidney

Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems

Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue.

Roles of Sca-1 in hematopoietic stem/progenitor cell function.

Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.

Relapsed ovarian cancer: challenges and management strategies for a chronic disease.

P2888

modpathol.2009.35

P304

817-23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2492953

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/MODPATHOL.2009.35

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24242426

http://www.w3.org/2001/XMLSchema#string

P6179

1035444364

http://www.w3.org/2001/XMLSchema#string

P698

19329942

http://www.w3.org/2001/XMLSchema#string

P921

P932

2692456

http://www.w3.org/2001/XMLSchema#string